Status:
WITHDRAWN
Tranexamic Acid in Gender Mastectomy
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Surgery
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this study is to examine the use of tranexamic acid (TXA) in gender mastectomy surgery, specifically looking at volume loss (blood and transudate) postoperatively.
Detailed Description
Anecdotal data from plastic surgeons around the country suggests that tranexamic acid has decreased patient's drain outputs, swelling, and bruising. Based on these anecdotal reports, many University o...
Eligibility Criteria
Inclusion
- Undergoing gender mastectomy
- English speaking
Exclusion
- History of thrombotic event (ie deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction)
- genetic disorder that increases risk of thrombosis
- use of estrogens at time of surgery
- pregnancy
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04372940
Start Date
January 1 2023
End Date
January 1 2024
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792